You are here

Managing Adverse Effects

Active Resources: 7

  • Recommended management strategies for HIV patients experiencing virologic failure (VF) while taking antiretroviral therapy (ART).

    Type: Training Materials
    Publish Date: 6/10/2021
  • This Fact Sheet Series is from the AIDSinfo/infoSIDA website. It reviews some of the major side effects of anti-HIV medications.

    Type: Clinical Reference Tools
    Publish Date: 9/24/2020
  • The National HIV Curriculum (NHC) offers free online continuing education for novice-to-expert health professionals, students, and faculty.

    Type: Online and Self-Paced Learning
    Publish Date: 9/14/2020
  • Slides from a 1-day course for primary care physicians and mid-level clinicians, which combines the latest research with current treatment guidelines for managing patients with HIV.

    Type: Training Materials
    Publish Date: 7/31/2020
  • Three sets of training slides covering what providers treating people with HIV should know about COVID-19.

    Type: Training Materials
    Publish Date: 4/9/2020
  • Excerpt from the Guidelines Introduction: "The Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) is a working group of

    Type: Guidelines
    Publish Date: 12/18/2019
  • This glossary of HIV/AIDS-related terms includes brief lay-oriented descriptions and illustrations. Materials are in the public domain and may be used freely.

    Type: Clinical Reference Tools
    Publish Date: 2/20/2019
    Review Date: 2/20/2019

Archive Resources: 3

Articles: 4

  • Weight Gain and Metabolic Complications with ART: Data from AIDS 2020

    Susa Coffey's picture

    Over the past few years, numerous studies have examined weight gain in people with HIV who start or change antiretroviral therapy (ART). While it is clear that some people gain excessive amounts of weight after starting (and sometimes upon changing) ART, the roles of specific antiretroviral (ARV...

  • Safety of Dolutegravir at Conception: Updated Data

    Susa Coffey's picture

    In 2018, initial results from the Tsepamo study of birth outcomes in Botswanan women treated with ART during pregnancy raised questions about the safety of dolutegravir (DTG) when given at the time of conception or very early in pregnancy. Specifically, an early interim analysis found a higher...

  • Switching from TDF/FTC to TAF/FTC

    Susa Coffey's picture

    Researchers at the 2016 Conference on Retroviruses and Opportunistic Infections presented results from a randomized double-blind, double-dummy switch study of TAF/FTC. Over 660 patients with virologic suppression on TDF/FTC-containing 3-drug regimens were either switched to TAF/FTC (200/10 mg...

  • Cobicistat and Stribild Use in Patients with Renal Insufficiency

    Ian R. McNicholl's picture

    Co-Author: Susa Coffey, MD; Medical Editor, AETC National Resource Center

    An open-label study is evaluating the renal safety of elvitegravir/cobicistat/emtricitabine/tenofovir (Stribild, or the "quad" pill) and cobicistat. For those patients with mild-to-...